Hadaschik B, Gillessen S, Sartor O. (177)Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer. J Nucl Med 2025 Sep 25:jnumed.125.270836. doi: 10.2967/jnumed.125.270836.
PMID: 40998732